These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33258448)

  • 21. In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi.
    Liendo A; Lazardi K; Urbina JA
    J Antimicrob Chemother; 1998 Feb; 41(2):197-205. PubMed ID: 9533461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease.
    Riley J; Brand S; Voice M; Caballero I; Calvo D; Read KD
    PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004014. PubMed ID: 26394211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel [1,2,3]triazolo[1,5-a]pyridine derivatives are trypanocidal by sterol biosynthesis pathway alteration.
    Lapier M; Ballesteros-Garrido R; Guzman-Rivera D; González-Herrera F; Aguilera-Venegas B; Moncada-Basualto M; Ballesteros R; Abarca B; Pesce B; Kemmerling U; Olea-Azar C; Maya JD
    Future Med Chem; 2019 May; 11(10):1137-1155. PubMed ID: 31280672
    [No Abstract]   [Full Text] [Related]  

  • 24. Trypanosoma cruzi CYP51 inhibitor derived from a Mycobacterium tuberculosis screen hit.
    Chen CK; Doyle PS; Yermalitskaya LV; Mackey ZB; Ang KK; McKerrow JH; Podust LM
    PLoS Negl Trop Dis; 2009; 3(2):e372. PubMed ID: 19190730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for rational design of inhibitors targeting Trypanosoma cruzi sterol 14α-demethylase: two regions of the enzyme molecule potentiate its inhibition.
    Friggeri L; Hargrove TY; Rachakonda G; Williams AD; Wawrzak Z; Di Santo R; De Vita D; Waterman MR; Tortorella S; Villalta F; Lepesheva GI
    J Med Chem; 2014 Aug; 57(15):6704-17. PubMed ID: 25033013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clear Shot at Primary Aim: Susceptibility of Trypanosoma cruzi Organelles, Structures and Molecular Targets to Drug Treatment.
    Menna-Barreto RF; de Castro SL
    Curr Top Med Chem; 2017; 17(10):1212-1234. PubMed ID: 27784255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ergosterol biosynthesis and drug development for Chagas disease.
    Urbina JA
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():311-8. PubMed ID: 19753490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-Aminopyridyl-based CYP51 inhibitors as anti-Trypanosoma cruzi drug leads with improved pharmacokinetic profile and in vivo potency.
    Calvet CM; Vieira DF; Choi JY; Kellar D; Cameron MD; Siqueira-Neto JL; Gut J; Johnston JB; Lin L; Khan S; McKerrow JH; Roush WR; Podust LM
    J Med Chem; 2014 Aug; 57(16):6989-7005. PubMed ID: 25101801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding the binding envelope of CYP51 inhibitors targeting Trypanosoma cruzi with 4-aminopyridyl-based sulfonamide derivatives.
    Vieira DF; Choi JY; Roush WR; Podust LM
    Chembiochem; 2014 May; 15(8):1111-20. PubMed ID: 24771705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitrypanosomal lead discovery: identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth.
    Andriani G; Amata E; Beatty J; Clements Z; Coffey BJ; Courtemanche G; Devine W; Erath J; Juda CE; Wawrzak Z; Wood JT; Lepesheva GI; Rodriguez A; Pollastri MP
    J Med Chem; 2013 Mar; 56(6):2556-67. PubMed ID: 23448316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sterol 14α-Demethylase from Trypanosomatidae Parasites as a Promising Target for Designing New Antiparasitic Agents.
    da Silva Santos-Júnior PF; Schmitt M; de Araújo-Júnior JX; da Silva-Júnior EF
    Curr Top Med Chem; 2021; 21(21):1900-1921. PubMed ID: 33655860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.
    Benaim G; Sanders JM; Garcia-Marchán Y; Colina C; Lira R; Caldera AR; Payares G; Sanoja C; Burgos JM; Leon-Rossell A; Concepcion JL; Schijman AG; Levin M; Oldfield E; Urbina JA
    J Med Chem; 2006 Feb; 49(3):892-9. PubMed ID: 16451055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sterol profiling of Leishmania parasites using a new HPLC-tandem mass spectrometry-based method and antifungal azoles as chemical probes reveals a key intermediate sterol that supports a branched ergosterol biosynthetic pathway.
    Feng M; Jin Y; Yang S; Joachim AM; Ning Y; Mori-Quiroz LM; Fromm J; Perera C; Zhang K; Werbovetz KA; Wang MZ
    Int J Parasitol Drugs Drug Resist; 2022 Dec; 20():27-42. PubMed ID: 35994895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
    Urbina JA; Payares G; Contreras LM; Liendo A; Sanoja C; Molina J; Piras M; Piras R; Perez N; Wincker P; Loebenberg D
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1771-7. PubMed ID: 9661019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of the sterol composition of Trypanosoma (Schizotrypanum) cruzi epimastigotes by delta 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole.
    Urbina JA; Vivas J; Visbal G; Contreras LM
    Mol Biochem Parasitol; 1995 Jul; 73(1-2):199-210. PubMed ID: 8577328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stress-Induced Proliferation and Cell Cycle Plasticity of Intracellular
    Dumoulin PC; Burleigh BA
    mBio; 2018 Jul; 9(4):. PubMed ID: 29991586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural complex of sterol 14α-demethylase (CYP51) with 14α-methylenecyclopropyl-Delta7-24, 25-dihydrolanosterol.
    Hargrove TY; Wawrzak Z; Liu J; Waterman MR; Nes WD; Lepesheva GI
    J Lipid Res; 2012 Feb; 53(2):311-20. PubMed ID: 22135275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of host central carbon metabolism and in situ glucose uptake by intracellular Trypanosoma cruzi amastigotes.
    Shah-Simpson S; Lentini G; Dumoulin PC; Burleigh BA
    PLoS Pathog; 2017 Nov; 13(11):e1006747. PubMed ID: 29176805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Planning new Trypanosoma cruzi CYP51 inhibitors using QSAR studies.
    de Oliveira PIC; de Santana Miranda PH; Lourenço EMG; de Santana Nogueira Silverio PS; Barbosa EG
    Mol Divers; 2021 Nov; 25(4):2219-2235. PubMed ID: 32557280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.